Autopsy report · NCT00757757
A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases
Cause of deathNo reason given
Life of this trial
- Ran for about 11 months before it stopped.
- 3 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Novartis Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Prostate Cancer; Bone Metastases
- Interventions
- MCS110
- Participants
- 3
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.